HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF

The present invention relates to a heteroaryl derivative and a use thereof. The heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR and/or HER2, and thus can be effectively used as a therapeutic agent for EGFR- and/or HER2-associated diseases. La présen...

Full description

Saved in:
Bibliographic Details
Main Authors RYU, Hee Sun, JUNG, Hong Ryul, JEON, Hyeon Ho, SON, Jung Beom, LEE, Young Yi, HWANG, Seon Ah, SHIM, In Seob, KIM, Sung Hwan, DO, Woo Mi, LEE, Youn Ho, KIM, Nam Doo
Format Patent
LanguageEnglish
French
Korean
Published 24.11.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a heteroaryl derivative and a use thereof. The heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR and/or HER2, and thus can be effectively used as a therapeutic agent for EGFR- and/or HER2-associated diseases. La présente invention concerne un dérivé hétéroaryle et son utilisation. Le dérivé hétéroaryle de la présente invention présente une excellente activité inhibitrice contre EGFR et/ou HER2, et peut ainsi être utilisé efficacement en tant qu'agent thérapeutique pour des maladies associées à EGFR et/ou HER2. 본 발명은 헤테로아릴 유도체 및 이의 용도에 관한 것이다. 본 발명의 헤테로아릴 유도체는 EGFR 및/또는 HER2에 대해 우수한 억제 활성을 나타내므로, 상기 EGFR 및/또는 HER2 관련 질환의 치료제로 유용하게 사용될 수 있다.
Bibliography:Application Number: WO2022KR06994